Realizing Effectiveness Across Continents with Hydroxyurea: Enrollment and Baseline Characteristics of the Multicenter REACH Study in sub-Saharan Africa

Despite its well-described safety and efficacy in the treatment of sickle cell anemia (SCA) in high-income settings, hydroxyurea remains largely unavailable in sub-Saharan Africa, where more than 75% of annual SCA births occur and many comorbidities exist. Realizing Effectiveness Across Continents w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Hematol
Autores principales: McGann, Patrick T., Williams, Thomas N., Olupot-Olupot, Peter, Tomlinson, George A., Lane, Adam, da Fonseca, José Luís Reis, Kitenge, Robert, Mochamah, George, Wabwire, Ham, Stuber, Susan, Howard, Thad A., McElhinney, Kathryn, Aygun, Banu, Latham, Teresa, Santos, Brígida, Tshilolo, Léon, Ware, Russell E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870803/
https://ncbi.nlm.nih.gov/pubmed/29318647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25034
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares